Abstract
We analyze the pharmaceutical market with a model of horizontal and vertical product differentiation. The implications from the model are tested on data from the Swedish pharmaceutical market. We find that vertically differentiated drugs gain larger market shares, command higher prices, and are less sensitive to substitutes than drugs that are only horizontally differentiated.